Focus: Reflow Medical is a newly founded (2024) medical device company specializing in catheters and peripheral intervention systems for cardiovascular and critical limb ischemia indications. With 1-50 employees and public status, it operates as an early-stage innovator in the vascular intervention space.
Profile data last refreshed 16h ago · AI intelligence enriched 3w ago
Reflow is a high-risk, high-reward early-stage medtech play with genuine regulatory momentum; best suited for operators who thrive in lean teams and can tolerate financial uncertainty for equity upside.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Reflow Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Reflow Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
CMS approves new technology add-on payment for Reflow Medical’s Spur system - Vascular News
CMS approves new technology add-on payment for Reflow Medical’s Spur system Vascular News
Cordis Introduces New PTA Drug-Eluting Balloon in Japan - Medical Product Outsourcing
Cordis Introduces New PTA Drug-Eluting Balloon in Japan Medical Product Outsourcing
Abbott’s Longer Length Esprit BTK Drug-Eluting Scaffold Gets FDA OK - Medical Product Outsourcing
Abbott’s Longer Length Esprit BTK Drug-Eluting Scaffold Gets FDA OK Medical Product Outsourcing
Reflow Medical Introduces Next-Gen Torqueable Microcatheters in U.S. - Medical Product Outsourcing
Reflow Medical Introduces Next-Gen Torqueable Microcatheters in U.S. Medical Product Outsourcing
First patient enrolled in study of Reflow Medical’s Spur system - Medical Device Network
First patient enrolled in study of Reflow Medical’s Spur system Medical Device Network
Reflow Medical enrolls first patient in retrievable scaffold trial - MassDevice
Reflow Medical enrolls first patient in retrievable scaffold trial MassDevice
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Early Tibial Vessel Recoil Following Treatment With the Bare Temporary Spur Stent System: Results From the DEEPER OUS Vessel Recoil Substudy.
Preclinical Evaluation of the Temporary Drug-Coated Spur Stent System in Porcine Peripheral Arteries.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo